Immuron IMRN
NASDAQ IMRN
$0.96 -0.06 (-5.87%)
As of: Oct 21, 2026 · 12:23 PM EDT

Immuron (IMRN) EBIT (2023 - 2024)

Updated

Immuron (IMRN) recorded EBIT of -$4.01 million in FY2026 (year ended Aug 28, 2026).

Analysis

Immuron (IMRN) EBIT (2023 - 2024) Analysis & Trends

Starting with FY2015, Immuron's EBIT history includes 12 fiscal years.

  • Annual EBIT has ranged from -$5.34 million in FY2025 to -$58,011 in FY2024 over the past five years.
  • Per Business Quant data, IMRN's EBIT was -$5.34 million in FY2025, -$58,011 in FY2024, -$2.02 million in FY2023 and -$1.89 million in FY2022.
Peer Set

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) EBIT (Qtr)
1 Eli Lilly 1,131.52 Bn 1,100.11 Bn 19.71 Bn 11.75 Bn
2 Johnson & Johnson 616.33 Bn 534.86 Bn 17.26 Bn 7.14 Bn
3 AbbVie 500.08 Bn 473.19 Bn 12.70 Bn 6.43 Bn
4 Merck 366.80 Bn 321.17 Bn 12.21 Bn -584.00 Mn
5 Novartis Ag 297.92 Bn 261.91 Bn 11.24 Bn 4.75 Bn
6 Astrazeneca 261.59 Bn 235.28 Bn 12.86 Bn 3.16 Bn
7 Amgen 234.86 Bn 190.26 Bn 7.24 Bn 3.51 Bn
8 Gilead Sciences 189.95 Bn 164.15 Bn 6.22 Bn -10.39 Bn
9 Pfizer 169.63 Bn 116.28 Bn 10.94 Bn 4.27 Bn
10 Immuron 7.13 Mn -10.02 Mn - -
Historic Data

Historic Data

Download Data
DateValue
Dec 31, 2024 -3.79 Mn
Sep 9, 2024 -38,654.88
Dec 31, 2023 -23,232.80
API Access

Immuron EBIT API

Pull this series into your own models, spreadsheets and apps with the Business Quant Historical Metrics API. The request below matches the chart above — change the frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.

https://data.businessquant.com/historic?slug=ebit&ticker=IMRN&period=max&api_key=YOUR_API_KEY